CRNX icon

Crinetics Pharmaceuticals
CRNX

49 hedge funds and large institutions have $463M invested in Crinetics Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$109M
2
+$77.9M
3
+$74.1M
4
O
OrbiMed
New York
+$54.8M
5
RCM
RA Capital Management
Massachusetts
+$48.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$453K
27
$451K
28
$381K
29
$353K
30
$341K
31
$313K
32
$302K
33
$287K
34
$268K
35
$260K
36
$132K
37
$97K
38
$91K
39
$75K
40
$57K
41
$57K
42
$56K
43
$47K
44
$46K
45
$36K
46
$30K
47
$16K
48
$9K
49
$1K
1
2